Published in J Urol on November 01, 2003
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst (2014) 1.42
Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer (2007) 1.28
Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer (2008) 1.28
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer (2010) 1.19
Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. Arch Surg (2012) 0.98
Radioactive iodine therapy decreases recurrence in thyroid papillary microcarcinoma. ISRN Endocrinol (2012) 0.97
Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer (2013) 0.94
Illness cognitions in head and neck squamous cell carcinoma: predicting quality of life outcome. Support Care Cancer (2009) 0.93
Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecological cancers. Gynecol Oncol (2012) 0.89
Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med (2012) 0.87
Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer. Ann Surg (2016) 0.85
Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer (2010) 0.82
An exploratory analysis of fear of recurrence among African-American breast cancer survivors. Int J Behav Med (2012) 0.81
Cancer Survivorship Care: Summarizing the 6 Tools for Success. Fed Pract (2011) 0.79
Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients. Patient (2008) 0.79
Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences. J Sex Med (2013) 0.79
Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplant (2014) 0.77
Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study. BMJ Open (2014) 0.75
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer. JAMA Oncol (2015) 0.75
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol (2002) 4.13
Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol (2003) 4.11
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr (2007) 3.49
Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Spirituality influences health related quality of life in men with prostate cancer. Psychooncology (2006) 2.65
Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer (2010) 2.61
Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA (2005) 2.56
Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol (2003) 2.44
Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41
Diffusion of surgical innovation among patients with kidney cancer. Cancer (2008) 2.38
Prostate cancer severity among low income, uninsured men. J Urol (2008) 2.38
Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst (2009) 2.28
Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. Arthritis Rheum (2007) 2.27
Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst (2010) 2.17
Comorbidity and competing risks for mortality in men with prostate cancer. Cancer (2011) 2.17
Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology (2009) 2.16
Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer (2014) 2.07
Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer (2014) 2.06
The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol (2006) 2.02
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer (2006) 1.97
Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer (2009) 1.95
Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer (2008) 1.89
Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87
Correlates of bother following treatment for clinically localized prostate cancer. J Urol (2010) 1.82
Variation in continence and potency by definition. J Urol (2003) 1.75
Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73
Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol (2009) 1.72
Pulmonary outcome prediction (POP) tools for cystic fibrosis patients. Pediatr Pulmonol (2010) 1.71
Variations in reconstruction after radical cystectomy. Cancer (2006) 1.69
Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med (2011) 1.69
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer (2004) 1.64
Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer (2010) 1.63
The demographic burden of urologic diseases in America. Urol Clin North Am (2009) 1.61
Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis. J Pediatr (2008) 1.60
Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol (2011) 1.59
Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med (2010) 1.59
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology (2005) 1.57
Emergency department revisits for patients with kidney stones in California. Acad Emerg Med (2015) 1.56
Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol (2007) 1.56
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer (2014) 1.55
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol (2004) 1.52
Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer (2013) 1.51
Health related quality of life in men with prostate cancer. J Urol (2003) 1.51
Trends in the surgical management of stress urinary incontinence among female Medicare beneficiaries, 2002-2007. Urology (2013) 1.49
Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49
Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology (2011) 1.48
The effect of concomitant prolapse repair on sling outcomes. J Urol (2008) 1.47
Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med (2010) 1.45
Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarction. Stroke (2006) 1.44
A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome. Urology (2010) 1.42
Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol (2007) 1.41
Patterns of care in testicular torsion: influence of hospital transfer on testicular outcomes. J Pediatr Urol (2013) 1.41
Improving decisions for men with prostate cancer: translational outcomes research. J Urol (2010) 1.41
Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates. Arthritis Rheum (2004) 1.41
Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries. Urology (2009) 1.41
Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study. Clin Drug Investig (2008) 1.40
External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res (2009) 1.40
A framework for modelling fertility motivation in couples. Popul Stud (Camb) (2004) 1.39
Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol (2008) 1.39
The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey. J Urol (2006) 1.36
Regret in men treated for localized prostate cancer. J Urol (2003) 1.35
The effect of age on outcomes of sling surgery for urinary incontinence. J Am Geriatr Soc (2007) 1.34
Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril (2010) 1.34
Shifting patterns of inhaled antibiotic use in cystic fibrosis. Pediatr Pulmonol (2008) 1.30
Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol (2008) 1.29
A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int (2005) 1.28
A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma. Cancer (2006) 1.28
Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. J Urol (2003) 1.25
Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry. J Urol (2011) 1.25
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis. Pediatr Pulmonol (2010) 1.23
Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain (2006) 1.22
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology (2002) 1.21
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample. Qual Life Res (2011) 1.21
Misconceptions and miscommunication among aging women with overactive bladder symptoms. Urology (2010) 1.20
Efficacy of osteopathic manipulation as an adjunctive treatment for hospitalized patients with pneumonia: a randomized controlled trial. Osteopath Med Prim Care (2010) 1.19
Confidence in the ability to communicate with physicians among low-income patients with prostate cancer. Urology (2004) 1.19
Women's experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups. Neurourol Urodyn (2011) 1.18
The role of provider volume on outcomes after sling surgery for stress urinary incontinence. J Urol (2007) 1.18
Renegotiating masculine identity after prostate cancer treatment. Qual Health Res (2008) 1.16
Pretreatment predictors of death from other causes in men with prostate cancer. J Urol (2008) 1.13
Variations in stress incontinence and prolapse management by surgeon specialty. J Urol (2007) 1.12
Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. Chest (2009) 1.11
Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int (2007) 1.10